497 related articles for article (PubMed ID: 15946254)
1. Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages.
Kao SJ; Lei HC; Kuo CT; Chang MS; Chen BC; Chang YC; Chiu WT; Lin CH
Immunology; 2005 Jul; 115(3):366-74. PubMed ID: 15946254
[TBL] [Abstract][Full Text] [Related]
2. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages.
Kengatharan M; De Kimpe SJ; Thiemermann C
Br J Pharmacol; 1996 Mar; 117(6):1163-70. PubMed ID: 8882611
[TBL] [Abstract][Full Text] [Related]
4. Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-kB-dependent mechanisms.
Kuo CT; Chiang LL; Lee CN; Yu MC; Bai KJ; Lee HM; Lee WS; Sheu JR; Lin CH
J Biomed Sci; 2003; 10(1):136-45. PubMed ID: 12607534
[TBL] [Abstract][Full Text] [Related]
5. Rac1 regulates peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway.
Chen BC; Kang JC; Lu YT; Hsu MJ; Liao CC; Chiu WT; Yeh FL; Lin CH
Mol Immunol; 2009 Mar; 46(6):1179-88. PubMed ID: 19118901
[TBL] [Abstract][Full Text] [Related]
6. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways of nitric oxide release in primary microglial culture challenged with gram-positive bacterial constituent, lipoteichoic acid.
Chien HF; Yeh KY; Jiang-Shieh YF; Wei IH; Chang CY; Chang ML; Wu CH
Neuroscience; 2005; 133(2):423-36. PubMed ID: 15878805
[TBL] [Abstract][Full Text] [Related]
8. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
9. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
10. Interaction of inflammatory and anti-inflammatory responses in microglia by Staphylococcus aureus-derived lipoteichoic acid.
Huang BR; Tsai CF; Lin HY; Tseng WP; Huang SS; Wu CR; Lin C; Yeh WL; Lu DY
Toxicol Appl Pharmacol; 2013 May; 269(1):43-50. PubMed ID: 23500011
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
Chen CC; Wang JK; Lin SB
J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
[TBL] [Abstract][Full Text] [Related]
12. Role of mitogen-activated protein kinases and tyrosine kinases on IL-1-Induced NF-kappaB activation and iNOS expression in bovine articular chondrocytes.
Mendes AF; Caramona MM; Carvalho AP; Lopes MC
Nitric Oxide; 2002 Feb; 6(1):35-44. PubMed ID: 11829533
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acid-induced cyclooxygenase-2 expression requires activations of p44/42 and p38 mitogen-activated protein kinase signal pathways.
Lin CH; Kuan IH; Wang CH; Lee HM; Lee WS; Sheu JR; Hsiao G; Wu CH; Kuo HP
Eur J Pharmacol; 2002 Aug; 450(1):1-9. PubMed ID: 12176102
[TBL] [Abstract][Full Text] [Related]
14. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
[TBL] [Abstract][Full Text] [Related]
16. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells.
Pahan K; Raymond JR; Singh I
J Biol Chem; 1999 Mar; 274(11):7528-36. PubMed ID: 10066820
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ICAM-1 expression on J774.2 macrophages by endotoxin involves activation of NF-kappaB but not protein tyrosine kinase: comparison to induction of iNOS.
Ruetten H; Thiemermann C; Perretti M
Mediators Inflamm; 1999; 8(2):77-84. PubMed ID: 10704144
[TBL] [Abstract][Full Text] [Related]
19. Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells.
Cruz MT; Duarte CB; Gonçalo M; Carvalho AP; Lopes MC
Am J Physiol; 1999 Dec; 277(6):C1050-7. PubMed ID: 10600756
[TBL] [Abstract][Full Text] [Related]
20. Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways.
Chiou WF; Don MJ; Liao JF; Wei BL
Eur J Pharmacol; 2011 Jan; 650(1):102-9. PubMed ID: 20951127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
